Gide's Life Sciences team to attend the 36th annual J.P. Morgan Healthcare Conference in San Francisco
4 January 2018
Event | USA | Healthcare, Pharmaceuticals & Life Sciences | 8-11 January 2018
Gide's Life Sciences team will attend the 36th annual J.P. Morgan Healthcare Conference in San Francisco from 8 to 11 January 2018. A great opportunity for Gide to discuss and share views with all actors of the healthcare sector on the future challenges of this fast-growing industry, the attractive investments opportunities, the upcoming restrictions and regulations, and the best way to assist our clients in this global ecosystem.
For the event, the team will comprise IP partner Raphaëlle Dequiré-Portier, M&A counsel Matthias Grolier, and Banking & Finance counsel Théophile Strebelle, all dedicated to the healthcare and biotech sectors. Feel free to contact them to meet and discuss any legal issues you may have.
One of the largest healthcare investment symposiums in the industry, the 2018 J.P. Morgan Healthcare Conference will gather more than 400 companies, both public and private, to deliver presentations to more than 8,000 attendees, providing a unique opportunity for investors to visit with many inter-related industry leaders in one setting.